Početna › Dijabetes tipa 1 › Washington
Kliničke studije za Dijabetes tipa 1 u državi Washington
20 studija za Dijabetes tipa 1 traži sudionike na lokacijama u državi Washington.
Gradovi u državi Washington
Službeni tekst studije (engleski)
Type 1 Diabetes Extension Study
- Benaroya Research Institute, Seattle
U tijeku regrutacijaOpažajna studija
Od 8 do 35 godina · Oba spola · Ažurirano 18. ruj 2026. · NCT02734277METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
U tijeku regrutacijaFaza 2
Od 18 do 69 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07699380A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
- MultiCare Mary Bridge Children's Health Center- Site Number : 8400037, Tacoma
U tijeku regrutacijaFaza 3
Od 1 do 25 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
U tijeku regrutacijaFaza 1/2
Od 12 do 35 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Benaroya Research Institute, Seattle
U tijeku regrutacijaFaza 2
Od 4 do 34 godina · Oba spola · Ažurirano 9. ruj 2026. · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Benaroya Research Institute, Seattle
U tijeku regrutacijaFaza 2
Od 8 do 45 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- Seattle Children's Hospital, Seattle
U tijeku regrutacijaFaza 1/2
Od 9 do 20 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07061574SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason, Seattle
- Mary Bridge Children's Outpatient Center - Tacoma, Tacoma
U tijeku regrutacijaFaza 2
Od 5 do 40 godina · Oba spola · Ažurirano 24. kol 2026. · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Washington, Seattle
U tijeku regrutacija
Od 18 do 65 godina · Oba spola · Ažurirano 16. srp 2026. · NCT06880835Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lip 2026. · NCT05822609Kidney Precision Medicine Project
- University of Washington, Seattle
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 14. tra 2026. · NCT04334707Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
- Rainier Clinical Reseach Center, Renton
U tijeku regrutacija
Od 18 do 65 godina · Oba spola · Ažurirano 9. tra 2026. · NCT07296276Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
- Rainier Clinical Research Center, Renton
U tijeku regrutacijaFaza 2
Od 18 do 50 godina · Oba spola · Ažurirano 6. tra 2026. · NCT06964087Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 24. ožu 2026. · NCT06217302Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
U tijeku regrutacijaFaza 3
Od 18 do 49 godina · Oba spola · Ažurirano 4. ožu 2026. · NCT05819138Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
- Seattle Children's, Seattle
U tijeku regrutacija
Od 16 do 19 godina · Oba spola · Ažurirano 30. pro 2025. · NCT07292558EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
- Benaroya Research Institute, Seattle
U tijeku regrutacijaOpažajna studija
Do 70 godina · Oba spola · Ažurirano 19. pro 2025. · NCT03369821InvesT1D: Promoting Adolescent Investment in Diabetes Care
- Seattle Children's, Seattle
U tijeku regrutacija
Od 12 godina i više · Oba spola · Ažurirano 16. pro 2025. · NCT06384911TrialNet Pathway to Prevention of T1D
- Benaroya Research Institute, Seattle
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 2 do 45 godina · Oba spola · Ažurirano 1. srp 2025. · NCT00097292MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
U tijeku regrutacijaFaza 1
Od 12 do 25 godina · Oba spola · Ažurirano 13. lip 2025. · NCT05065372Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.